SCHEMBL95879

SCHEMBL95879

CC(=O)Oc1ccc(CO)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
CYP4F2 P78329 2/20 0.55
CYP4A11 Q02928 2/20 0.55
MAPT P10636 3/20 0.53
POLB P06746 1/20 0.53
PKM P14618 1/20 0.53
ELANE P08246 2/20 0.52
PPARG P37231 1/20 0.52
PPARA Q07869 1/20 0.52
HSD17B10 Q99714 1/20 0.50
ESR1 P03372 1/20 0.49
PGR P06401 1/20 0.49
CHRM2 P08172 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
AR P10275 1/20 0.49
CHRM1 P11229 1/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
GAA P10253 2/20 0.48
ALDH1A1 P00352 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23783490 0.89 ELANE (0.51) LMNACYP4F2CYP4A11MAPTPOLB
SCHEMBL1394966 0.84 LTA4H (0.54) LMNACYP4F2CYP4A11ELANEPPARG
SCHEMBL9081470 0.84 LMNA (0.61) LMNACYP4F2CYP4A11MAPTPOLB
SCHEMBL777803 0.84 ELANE (0.62) LMNAMAPTPOLBPKMELANE
SCHEMBL269329 0.83 LMNA (0.80) LMNAMAPTPOLBPKMELANE
SCHEMBL6662199 0.83 PTGS2 (0.65) LMNACYP4F2CYP4A11MAPTPOLB
SCHEMBL95878 0.83 LMNA (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL68678 0.83 LMNA (0.59) LMNAMAPTPOLBPKMELANE
SCHEMBL15281008 0.82 ELANE (0.49) LMNACYP4F2CYP4A11MAPTPOLB
SCHEMBL1394964 0.82 PPARG (0.50) LMNACYP4F2CYP4A11MAPTELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US claimed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US claimed
EP-3507295-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES Mireca Medicines GmbH (DE) 2019-07-10 EP claimed
CN-106478576-B A kind of fluorescence probe and the preparation method and application thereof for detecting carboxy-lesterase 华南理工大学 2019-01-18 CN claimed
WO-2018041942-A9 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2019-01-17 WO claimed
WO-2018041942-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES BIOLOG LIFE SCIENCE INSTITUTE FORSCHUNGSLABOR UND BIOCHEMICA-VERTRIEB GMBH (DE) 2018-03-08 WO claimed
CN-106478576-A A kind of for detecting fluorescence probe of carboxy-lesterase and preparation method and application 华南理工大学 2017-03-08 CN claimed
US-8772502-B2 Alkylsulfinyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2014-07-08 US claimed
EP-2635124-A1 ALKYLSULFINYL-SUBSTITUTED THIAZOLIDE COMPOUNDS Romark Laboratories, L.C. (US) 2013-09-11 EP claimed
WO-2012061190-A1 ALKYLSULFINYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2012-05-10 WO claimed
WO-2012058378-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES ROMARK LABORATORIES L.C. (US) 2012-05-03 WO claimed
US-20120108591-A1 ALKYLSULFINYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-03 US claimed
US-20120108592-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES ROMARK LABORATORIES, L.C. 2012-05-03 US claimed
EP-1575990-B1 Solid phase bound PNA-dimers and their synthesis APPLERA CORP (US) 2009-11-18 EP claimed
WO-2006061600-A1 PARTICLES FOR USE AS A SOLID SUPPORT AND PROCESS FOR THEIR PREPARATION UNIVERSITY OF SOUTHAMPTON (GB) 2006-06-15 WO claimed
EP-1373167-A2 SOLID PHASE SYNTHESIS SUPPORTS AND METHODS 3M Innovative Properties Company (US) 2004-01-02 EP claimed
WO-2002081078-A2 SOLID PHASE SYNTHESIS SUPPORTS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-10-17 WO claimed
WO-2025043219-A1 METHODS FOR UNCAGING TETRAZINES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-02-27 WO disclosed
US-3994875-A CEPHALOSPORINS, PENICILLINS YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) 1976-11-30 US disclosed
US-3948904-A ANTIBIOTICS YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 LMNA 2780/4885CYP4F2 4213/4885CYP4A11 4310/4885
US-20120108592-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF SALICYLANILIDES FOR TREATMENT OF HEPATITIS VIRUSES PYGL, GYS2, GLS2 LMNA 3131/4885CYP4F2 395/4885CYP4A11 67/4885
US-20120108591-A1 ALKYLSULFINYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, HCCS LMNA 3547/4885CYP4F2 1524/4885CYP4A11 769/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A LMNA 3030/4885CYP4F2 4214/4885CYP4A11 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.